Stay updated on BMS-986466 Combo in KRAS G12C Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986466 Combo in KRAS G12C Solid Tumors Clinical Trial page.

Latest updates to the BMS-986466 Combo in KRAS G12C Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedAdded a site-wide notice about potential data currency issues due to a lapse in government funding, including NIH Clinical Center status and links to cc.nih.gov and opm.gov; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check9 days agoChange DetectedThe page now includes a glossary toggle and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. These changes affect presentation of metadata rather than core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor documentation/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page adds new Locations sections for California, Georgia, New Jersey, New South Wales, Central District, and Tell Abīb, and removes the corresponding Locations subsections (California Locations, Georgia Locations, New Jersey Locations, New South Wales Locations, Central District Locations, Tell Abīb Locations). The revision version is updated to v3.3.3.SummaryDifference0.6%

- Check72 days agoChange DetectedThe page's revision history shows an update from v3.2.0 to v3.3.2, which does not alter study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedDeleted the government funding/operating status notice from the page, while core study details, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to BMS-986466 Combo in KRAS G12C Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986466 Combo in KRAS G12C Solid Tumors Clinical Trial page.